Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Incyte Corporation(INCY) | 36,179,665 | 30,738,524 | -5,441,141 | $2.06B | $1.86B | 23.81% | -$197.79M |
| BeOne Medicines AGADR(ONC) | 10,568,897 | 10,568,897 | 0 | $1.65B | $1.51B | 19.27% | -$145.01M |
| ACADIA Pharmaceuticals Inc. | 42,864,612 | 42,877,916 | +13,304 | $792.57M | $696.77M | 8.90% | -$95.80M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,969,798 | 1,974,590 | +4,792 | $526.01M | $553.20M | 7.07% | +$27.19M |
| Revolution Medicines, Inc.(RVMD) | 7,549,249 | 7,569,090 | +19,841 | $243.31M | $293.76M | 3.75% | +$50.44M |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 6,398,365 | 6,398,365 | 0 | $277.24M | $262.72M | 3.36% | -$14.52M |
| Insmed Incorporated(INSM) | 343,000 | 3,576,038 | +3,233,038 | $9.31M | $239.59M | 3.06% | +$230.29M |
| Bicycle Therapeutics plcADS | 4,942,823 | 9,399,960 | +4,457,137 | $123.08M | $190.26M | 2.43% | +$67.18M |
| Summit Therapeutics Inc.(SMMT) | 0 | 23,222,222 | +23,222,222 | $0 | $181.13M | 2.31% | +$181.13M |
| Kymera Therapeutics, Inc.(KYMR) | 5,995,928 | 5,995,928 | 0 | $241.04M | $178.98M | 2.29% | -$62.06M |
| Edgewise Therapeutics, Inc.(EWTX) | 5,840,059 | 5,840,059 | 0 | $106.52M | $105.18M | 1.34% | -$1.34M |
| Alkermes plcSHS(ALKS) | 0 | 4,181,751 | +4,181,751 | $0 | $100.78M | 1.29% | +$100.78M |
| Insmed IncorporatedNOTE 0 75 6 1 2028(INSM) | 0 | 0 | 0 | $0 | $90.41M | 1.16% | +$90.41M |
| Replimune Group, Inc.(REPL) | 9,545,336 | 10,045,336 | +500,000 | $77.99M | $90.41M | 1.16% | +$12.42M |
| Denali Therapeutics Inc.(DNLI) | 3,731,695 | 3,731,695 | 0 | $76.57M | $86.65M | 1.11% | +$10.08M |
| AbCellera Biologics Inc.(ABCL) | 27,525,640 | 27,525,640 | 0 | $124.69M | $81.48M | 1.04% | -$43.22M |
| Nurix Therapeutics, Inc.(NRIX) | 3,882,125 | 3,882,125 | 0 | $57.07M | $81.02M | 1.04% | +$23.95M |
| Immatics N.V.SHS(IMTX) | 6,443,398 | 6,443,398 | 0 | $67.72M | $74.87M | 0.96% | +$7.15M |
| Entrada Therapeutics, Inc.(TRDA) | 4,865,819 | 4,865,819 | 0 | $68.95M | $69.34M | 0.89% | +$389.3K |
| Ultragenyx Pharmaceutical Inc.(RARE) | 1,466,547 | 1,466,547 | 0 | $68.47M | $60.28M | 0.77% | -$8.20M |
| Stoke Therapeutics, Inc.(STOK) | 3,368,443 | 4,368,443 | +1,000,000 | $45.47M | $59.02M | 0.75% | +$13.54M |
| Insmed IncorporatedNOTE 1 75 1 15 2025(INSM) | 0 | 0 | 0 | $0 | $56.19M | 0.72% | +$56.19M |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 0 | 2,818,323 | +2,818,323 | $0 | $52.62M | 0.67% | +$52.62M |
| Immunocore Holdings plcADS(IMCR) | 1,515,318 | 1,515,318 | 0 | $98.50M | $51.35M | 0.66% | -$47.14M |
| argenx SEADR(ARGX) | 151,215 | 111,904 | -39,311 | $59.54M | $48.12M | 0.61% | -$11.41M |
| Kodiak Sciences Inc.(KOD) | 17,310,490 | 17,310,490 | 0 | $91.05M | $40.68M | 0.52% | -$50.37M |
| Xenon Pharmaceuticals Inc.(XENE) | 993,679 | 993,679 | 0 | $42.78M | $38.74M | 0.50% | -$4.03M |
| Prelude Therapeutics Incorporated(PRLD) | 10,123,824 | 10,123,824 | 0 | $47.99M | $38.57M | 0.49% | -$9.42M |
| IDEAYA Biosciences, Inc.(IDYA) | 1,062,123 | 1,062,123 | 0 | $46.61M | $37.29M | 0.48% | -$9.31M |
| Cerus Corporation(CERS) | 19,477,339 | 19,477,339 | 0 | $36.81M | $34.28M | 0.44% | -$2.53M |
| Sera Prognostics, Inc.CL A(SERA) | 5,434,399 | 5,434,399 | 0 | $49.45M | $32.17M | 0.41% | -$17.28M |
| Krystal Biotech, Inc.(KRYS) | 169,934 | 169,934 | 0 | $30.24M | $31.21M | 0.40% | +$970.3K |
| Celcuity Inc.(CELC) | 1,552,478 | 1,874,978 | +322,500 | $33.53M | $30.71M | 0.39% | -$2.82M |
| Roivant Sciences Ltd.SHS(ROIV) | 7,413,834 | 2,798,716 | -4,615,118 | $78.14M | $29.58M | 0.38% | -$48.56M |
| IGM Biosciences, Inc. | 4,088,322 | 4,090,316 | +1,994 | $39.45M | $28.10M | 0.36% | -$11.35M |
| Cerevel Therapeutics Holdings, Inc. | 1,600,000 | 683,588 | -916,412 | $67.63M | $27.95M | 0.36% | -$39.68M |
| Akero Therapeutics, Inc. | 2,713,205 | 1,097,082 | -1,616,123 | $68.54M | $25.74M | 0.33% | -$42.80M |
| Dyne Therapeutics, Inc.(DYN) | 285,000 | 672,096 | +387,096 | $8.09M | $23.72M | 0.30% | +$15.63M |
| Alumis Inc. | 0 | 1,562,500 | +1,562,500 | $0 | $20.78M | 0.27% | +$20.78M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 4,916,095 | 4,916,095 | 0 | $34.66M | $18.39M | 0.23% | -$16.27M |
| Merus N.V. | 0 | 300,000 | +300,000 | $0 | $17.75M | 0.23% | +$17.75M |
| Neurogene Inc.(NGNE) | 456,015 | 456,015 | 0 | $23.21M | $16.59M | 0.21% | -$6.62M |
| TScan Therapeutics, Inc.(TCRX) | 2,784,792 | 2,784,792 | 0 | $22.11M | $16.29M | 0.21% | -$5.82M |
| Sana Biotechnology, Inc.(SANA) | 2,380,949 | 2,380,949 | 0 | $23.81M | $13.00M | 0.17% | -$10.81M |
| Immunovant, Inc.(IMVT) | 425,009 | 464,718 | +39,709 | $13.73M | $12.27M | 0.16% | -$1.46M |
| Xencor, Inc.(XNCR) | 545,431 | 545,431 | 0 | $12.07M | $10.33M | 0.13% | -$1.75M |
| Neumora Therapeutics, Inc.(NMRA) | 633,851 | 1,034,600 | +400,749 | $8.72M | $10.17M | 0.13% | +$1.45M |
| Fate Therapeutics, Inc.(FATE) | 1,818,181 | 2,997,772 | +1,179,591 | $13.35M | $9.83M | 0.13% | -$3.51M |
| 2seventy bio, Inc. | 2,497,526 | 2,497,526 | 0 | $13.36M | $9.62M | 0.12% | -$3.75M |
| Biomea Fusion, Inc.(BMEA) | 2,108,949 | 2,108,949 | 0 | $31.53M | $9.49M | 0.12% | -$22.04M |
| Celldex Therapeutics, Inc.(CLDX) | 247,644 | 247,644 | 0 | $10.39M | $9.17M | 0.12% | -$1.23M |
| Taysha Gene Therapies, Inc.(TSHA) | 4,004,756 | 4,004,756 | 0 | $11.49M | $8.97M | 0.11% | -$2.52M |
| Athira Pharma, Inc. | 3,153,807 | 3,153,807 | 0 | $8.64M | $8.36M | 0.11% | -$283.8K |
| Verve Therapeutics, Inc. | 1,691,530 | 1,691,530 | 0 | $22.46M | $8.25M | 0.11% | -$14.21M |
| Relay Therapeutics, Inc.(RLAY) | 1,160,117 | 1,160,117 | 0 | $9.63M | $7.56M | 0.10% | -$2.07M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 190,476 | 190,476 | 0 | $4.78M | $6.51M | 0.08% | +$1.73M |
| Tango Therapeutics, Inc.(TNGX) | 750,000 | 750,000 | 0 | $5.96M | $6.43M | 0.08% | +$480.0K |
| KALA BIO, Inc.(KALA) | 266,613 | 891,335 | +624,722 | $2.12M | $6.32M | 0.08% | +$4.19M |
| DBV Technologies S.A.ADR | 0 | 7,307,131 | +7,307,131 | $0 | $5.85M | 0.07% | +$5.85M |
| Design Therapeutics, Inc.(DSGN) | 1,662,120 | 1,695,294 | +33,174 | $6.70M | $5.68M | 0.07% | -$1.02M |
| Contineum Therapeutics, Inc.CL A(CTNM) | 0 | 312,500 | +312,500 | $0 | $5.50M | 0.07% | +$5.50M |
| Praxis Precision Medicines, Inc.(PRAX) | 131,533 | 131,533 | 0 | $8.03M | $5.44M | 0.07% | -$2.59M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 0 | 100,000 | +100,000 | $0 | $5.40M | 0.07% | +$5.40M |
| Prime Medicine, Inc.(PRME) | 1,028,466 | 1,028,466 | 0 | $7.20M | $5.29M | 0.07% | -$1.91M |
| Centessa Pharmaceuticals plcADS | 0 | 549,212 | +549,212 | $0 | $4.96M | 0.06% | +$4.96M |
| HOOKIPA Pharma Inc. | 0 | 8,128,151 | +8,128,151 | $0 | $4.81M | 0.06% | +$4.81M |
| Sagimet Biosciences Inc.COM SER A(SGMT) | 1,381,898 | 1,381,898 | 0 | $7.49M | $4.73M | 0.06% | -$2.76M |
| Crinetics Pharmaceuticals, Inc. | 0 | 103,927 | +103,927 | $0 | $4.65M | 0.06% | +$4.65M |
| Talis Biomedical Corporation | 508,323 | 508,323 | 0 | $4.45M | $4.40M | 0.06% | -$44.8K |
| Alector, Inc. | 0 | 927,264 | +927,264 | $0 | $4.21M | 0.05% | +$4.21M |
| Ceryvyn Therapeutics LimitedADS(CKDXF) | 2,177,826 | 2,173,622 | -4,204 | $8.95M | $4.20M | 0.05% | -$4.76M |
| Skye Bioscience, Inc.(SKYE) | 0 | 500,000 | +500,000 | $0 | $4.00M | 0.05% | +$4.00M |
| Vaxcyte, Inc.(PCVX) | 48,885 | 48,885 | 0 | $3.34M | $3.69M | 0.05% | +$352.0K |
| Arcturus Therapeutics Holdings Inc.(ARCT) | 0 | 151,329 | +151,329 | $0 | $3.68M | 0.05% | +$3.68M |
| Generation Bio Co. | 371,219 | 1,206,957 | +835,738 | $1.51M | $3.40M | 0.04% | +$1.89M |
| Enliven Therapeutics, Inc. | 114,833 | 114,833 | 0 | $2.02M | $2.68M | 0.03% | +$663.7K |
| Cypherpunk Technologies Inc.(CYPH) | 1,172,175 | 1,172,175 | 0 | $3.12M | $2.30M | 0.03% | -$820.5K |
| Adaptimmune Therapeutics plcADR(ADAPY) | 10,787,022 | 2,343,695 | -8,443,327 | $17.04M | $2.28M | 0.03% | -$14.76M |
| Mersana Therapeutics, Inc. | 1,086,115 | 1,086,115 | 0 | $4.87M | $2.18M | 0.03% | -$2.68M |
| Century Therapeutics, Inc.(IPSC) | 797,460 | 797,460 | 0 | $3.33M | $2.03M | 0.03% | -$1.30M |
| NewAmsterdam Pharma Company N.V. ORDINARY SHARES | 96,827 | 96,827 | 0 | $2.29M | $1.86M | 0.02% | -$429.9K |
| Sage Therapeutics, Inc. | 407,217 | 171,026 | -236,191 | $7.63M | $1.86M | 0.02% | -$5.77M |
| vTv Therapeutics Inc.CL A(VTVT) | 97,314 | 97,314 | 0 | $2.29M | $1.72M | 0.02% | -$571.2K |
| Compass Therapeutics, Inc.(CMPX) | 1,557,630 | 1,557,630 | 0 | $3.08M | $1.56M | 0.02% | -$1.53M |
| Protara Therapeutics, Inc.(TARA) | 199,671 | 536,832 | +337,161 | $800.7K | $1.12M | 0.01% | +$315.9K |
| Aerovate Therapeutics, Inc. | 1,680,517 | 628,939 | -1,051,578 | $49.69M | $1.04M | 0.01% | -$48.65M |
| Pfizer Inc.(PFE) | 35,000 | 35,000 | 0 | $971.3K | $979.3K | 0.01% | +$8.1K |
| Achilles Therapeutics plcADS | 1,208,775 | 1,108,767 | -100,008 | $1.51M | $903.6K | 0.01% | -$607.3K |
| Aligos Therapeutics, Inc. | 2,076,400 | 2,076,400 | 0 | $2.03M | $726.7K | 0.01% | -$1.31M |
| PMV Pharmaceuticals, Inc.(PMVP) | 322,024 | 322,024 | 0 | $547.4K | $521.7K | 0.01% | -$25.8K |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 10,126,176 | 75,778 | -10,050,398 | $51.44M | $468.3K | 0.01% | -$50.97M |
| Acrivon Therapeutics, Inc. | 52,885 | 52,885 | 0 | $378.1K | $306.7K | 0.00% | -$71.4K |
| Foghorn Therapeutics Inc.(FHTX) | 45,027 | 45,027 | 0 | $302.1K | $258.9K | 0.00% | -$43.2K |
| Tyra Biosciences, Inc.(TYRA) | 10,607 | 10,607 | 0 | $174.0K | $169.6K | 0.00% | -$4.3K |
| Surrozen, Inc.W EXP 8 11 2026(SRZN) | 833,333 | 833,333 | 0 | $25.2K | $13.8K | 0.00% | -$11.3K |
| 4D Molecular Therapeutics, Inc. | 100,000 | 0 | -100,000 | $3.19M | $0 | — | -$3.19M |
| Alpine Immune Sciences, Inc. | 81,578 | 0 | -81,578 | $3.23M | $0 | — | -$3.23M |
| Cabaletta Bio, Inc.(CABA) | 13,331 | 0 | -13,331 | $227.4K | $0 | — | -$227.4K |
| DBV Technologies S.A.ADR | 14,614,264 | 0 | -14,614,264 | $10.95M | $0 | — | -$10.95M |
| HOOKIPA Pharma Inc. | 8,128,151 | 0 | -8,128,151 | $5.79M | $0 | — | -$5.79M |